drugset / Trial / NCT01124981

Haemocomplettan® P During Elective Complex Cardiac Surgery

NCT01124981

Phase 2/3 Completed 120 enrolled Isala CSL Behring · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Fibrinogen concentrate is increasingly used in cardiac surgery to reverse coagulopathy. Whether its use reduces blood loss, transfusion and occurrence of clinical adverse events remains unknown.

Timeline

Start
2011-02
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic Intravenous